To further explore the potential oncogenic mechanisms of TRP family genes, we comprehensively described the number of genetic alterations in TRP family genes, including mutations, fusions, amplifications, homozygous deletions, and methylations, and found that TRPM6 through deleterious mutations and TRPC4AP through increased CNVs may promote tumour progression. This evidence concerns the gene TRPC4AP and neoplasm.